Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development
The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...
Fierce Biotech3d
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Alphabet’s AI Drug Unit Raises $600 Million From OpenAI Backer
Isomorphic Labs, the Alphabet Inc.-owned company that uses artificial intelligence to discover drugs, has raised $600 million ...